Evidence map›Paper›PMID 38769664›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Metabolic Recoding of NSUN2-Mediated m

Baoxiang Chen, Yanrong Deng, Yuntian Hong, Lifang Fan, Xiang Zhai, Heng Hu, Siyuan Yin, Quanjiao Chen, Xiaoyu Xie, Xianghai Ren and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed.

  1. Cancer biology & therapy · 2026
    Article
  2. Review
  3. Lactate-Mediated Lysine Lactylation in Renal Fibrosis: Current Progress and Challenges.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  4. NSUN2-Mediated mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Research progress of lactylation modification in tumors (Review).Experimental and therapeutic medicine · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Baoxiang ChenDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.ORCID 0000-0002-7725-8275
Yanrong DengDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Yuntian HongDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Lifang FanDepartment of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Xiang ZhaiDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Heng HuDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Siyuan YinDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Quanjiao ChenCAS Key Laboratory of Special Pathogens and Biosafety, CAS Center for Influenza Research and Early Warning, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430064, China.
Xiaoyu XieDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Xianghai RenDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Jianhong ZhaoDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Congqing JiangDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.ORCID 0000-0001-6324-5740

Funding

Enginerring construction project of improving diagnosis and treatment ability of difficult diseases(oncology) ZLYNXM202012Joint Foundation of Health Commission of Hubei Province znpy 2019086Zhongnan Hospital of Wuhan University Medical Science and Technology Innovation Platform Construction Support Project PTXM2023028
6 · The paper itself

Abstract

The RNA modification, 5-methylcytosine (m

Indexed as

Colorectal NeoplasmsDisease ProgressionDNA-Binding ProteinsAnimalsBiomarkers, TumorCell Line, TumorDisease Models, AnimalFeedback, PhysiologicalGene Expression Regulation, NeoplasticHumansMethyltransferasesMicePhosphopyruvate HydrataseTumor Suppressor ProteinsBiomarkers, TumorDNA-Binding ProteinsENO1 protein, humanMethyltransferasesNSUN2 protein, humanPhosphopyruvate HydrataseTumor Suppressor Proteins5‐methylcytosinecolorectal cancerENO1lactylationNSUN2YBX1

Identifiers

PMID38769664
PMCPMC11267267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.